Applied Dna Sciences Inc (APDN)
0.8616 +0.0145 (+1.71%) 04/28/25 [NASDAQ]
0.8600 x 5,300 0.8700 x 1,100
Realtime by (Cboe BZX)
0.8600 x 5,300 0.8700 x 1,100
Realtime 0.8600 -0.0016 (-) 06:12 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,088 | -10,023 | -8,270 | -14,278 | -13,029 |
| Depreciation Amortization | 696 | 1,362 | 1,291 | 844 | 312 |
| Accounts receivable | -107 | 3,051 | -533 | -2,638 | 600 |
| Other Working Capital | -1,140 | 2,447 | 955 | -3,616 | 528 |
| Other Operating Activity | -6,073 | -3,055 | -2,419 | 6,300 | 446 |
| Operating Cash Flow | $-13,711 | $-6,218 | $-8,977 | $-13,388 | $-11,143 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -408 | -33 | -490 | -2,549 | -1,064 |
| Purchase Sale Intangibles | 0 | -1,062 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,062 | 0 | 0 | 0 |
| Investing Cash Flow | $-408 | $-1,096 | $-490 | $-2,549 | $-1,064 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 847 |
| Debt Repayment | N/A | N/A | N/A | -1,666 | -108 |
| Common Stock Issued | 13,399 | N/A | 18,127 | 16,370 | 18,696 |
| Financing Cash Flow | $13,399 | $N/A | $18,127 | $14,705 | $19,435 |
| Beginning Cash Position | 7,902 | 15,215 | 6,555 | 7,787 | 559 |
| End Cash Position | 7,181 | 7,902 | 15,215 | 6,555 | 7,787 |
| Net Cash Flow | $-721 | $-7,314 | $8,660 | $-1,232 | $7,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,711 | -6,218 | -8,977 | -13,388 | -11,143 |
| Capital Expenditure | -408 | -78 | -490 | -2,549 | -1,064 |
| Free Cash Flow | -14,119 | -6,296 | -9,466 | -15,937 | -12,207 |